Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SULFASALAZINE Cause Malignant neoplasm progression? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with SULFASALAZINE (Azulfidine EN-tabs). This represents 0.0% of all adverse event reports for SULFASALAZINE.

5
Reports of Malignant neoplasm progression with SULFASALAZINE
0.0%
of all SULFASALAZINE reports
4
Deaths
4
Hospitalizations

How Dangerous Is Malignant neoplasm progression From SULFASALAZINE?

Of the 5 reports, 4 (80.0%) resulted in death, 4 (80.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SULFASALAZINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does SULFASALAZINE Cause?

Drug ineffective (22,365) Rheumatoid arthritis (15,136) Drug intolerance (11,530) Pain (11,309) Fatigue (9,684) Joint swelling (9,673) Rash (8,739) Contraindicated product administered (8,698) Arthralgia (8,527) Abdominal discomfort (8,404)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which SULFASALAZINE Alternatives Have Lower Malignant neoplasm progression Risk?

SULFASALAZINE vs SULFATHIAZOLE SULFASALAZINE vs SULFISOMIDINE SULFASALAZINE vs SULFUR SULFASALAZINE vs SULFUR HEXAFLUORIDE SULFASALAZINE vs SULINDAC

Related Pages

SULFASALAZINE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression SULFASALAZINE Demographics